Hepatitis C and tumors: immune checkpoint inhibitors safe and effective?

被引：0
|
作者：
Simon, Annika
机构：
来源：
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2024年 / 62卷 / 02期
关键词：
D O I：
10.1055/a-2181-4090
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Wirkstoffe aus der Gruppe der Immun-Checkpoint-Inhibitoren (ICI) haben in den letzten Jahren die Krebstherapie revolutioniert und konnten auch fur Patient*innen mit soliden Tumorerkrankungen und komorbider chronischer Hepatitis-C-Infektion eine neue Therapieoption darstellen. Yibirin et al. wollten daher mehr uber den virologischen Einfluss der ICI und ihre Sicherheit erfahren, und haben eine prospektive Beobachtungsstudie zum Thema durchgefuhrt.
引用
收藏
页码：156 / 158
页数：2
相关论文
共 50 条
  • [1] Immune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors
    Yibirin, Marcel
    Mustafayev, Khalis
    Hosry, Jeff
    Pundhir, Pooja
    Klingen, Joseph
    Guevara, Eduardo Yepez
    Granwehr, Bruno P.
    Kaseb, Ahmed
    Naing, Aung
    Patel, Sapna
    Shah, Amishi Y.
    Skoulidis, Ferdinandos
    Tawbi, Hussein A.
    Wang, Lan
    Miller, Ethan
    Zhang, Hao Chi
    Zurita-Saavedra, Amado
    Torres, Harrys A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (09): : 1609 - 1617
  • [2] IMMUNE CHECKPOINT INHIBITORS SUPPRESS HEPATITIS C VIRUS REPLICATION IN INFECTED PATIENTS WITH SOLID TUMORS
    Yibirin, Marcel
    Mustafayev, Khalis
    Hosry, Jeff
    Pundhir, Pooja
    Klingen, Joseph
    Yepez-Guevara, Eduardo
    Granwehr, Bruno
    Kaseb, Ahmed Omar
    Naing, Aung
    Patel, Sapna
    Shah, Amishi Y.
    Skoulidis, Ferdinandos
    Tawbi, Hussein A.
    Wang, Lan S.
    Miller, Ethan D.
    Zhang, Hao Chi
    Zurita-Saavedra, Amado
    Torres, Harrys A.
    HEPATOLOGY, 2022, 76 : S337 - S338
  • [3] Melanoma Therapy with Immune checkpoint-Inhibitors during Dialysis - safe and effective
    Zahn, A.
    Lebahn, H.
    Schneider, L.
    Ludwig-Peitsch, W. K.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 69 - 69
  • [4] Thymic tumors and immune checkpoint inhibitors
    Yokoyama, Shintaro
    Miyoshi, Hiroaki
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1509 - S1515
  • [5] Checkpoint A: An Atypical Presentation of Hepatitis A on Immune Checkpoint Inhibitors
    Czech, Torrey
    Placek, Alexander
    Young, Kraig
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S1198 - S1198
  • [6] IS IMMUNE CHECKPOINT INHIBITORS THERAPIES SAFE AND EFFECTIVE FOR PATIENTS WITH CANCER AND PREEXISTING AUTOIMMUNE DISEASE?
    Xie, W.
    Huang, H.
    Zhang, Z.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 83 - 83
  • [7] Efficacy and safety of immune checkpoint inhibitors in advanced solid tumors with hepatitis B infection
    Niu, Ruiqi
    Du, Yingying
    Qian, Hesheng
    Pang, Jingdan
    Zeng, Xinyan
    Chen, Sheng
    Wang, Jing
    Wu, Wentian
    Shao, Changchun
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Immune Checkpoint Inhibitors-Induced Hepatitis
    Tian, Yun
    Abu-Sbeih, Hamzah
    Wang, Yinghong
    IMMUNOTHERAPY, 2ND EDITION, 2018, 995 : 159 - 164
  • [9] Immune Checkpoint Inhibitors in Progressive Neuroendocrine Tumors
    Chauhan, Aman
    Anthony, Lowell
    PANCREAS, 2018, 47 (03) : 335 - 335
  • [10] Biomarkers for immune checkpoint inhibitors in solid tumors
    Kapoor, Vidit
    Kelly, William James
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (01): : 126 - 136
12345